Myriad Genetics | MYGN - Les Charges D'Exploitation





Les Charges D'Exploitation Changement Date
Agilent USD 1.44B 9M 2026-03
Becton, Dickinson and Co. USD 24.13B 19.54B 2026-03
Bio-Rad Laboratories USD 6.85B 6.21B 2026-03
Bruker USD 813.2M 87.7M 2026-03
Danaher USD 52.95B 47.61B 2026-03
Illumina USD 852M 51M 2026-03
J&J USD 17.44B 1.53B 2026-03
Mettler Toledo International USD 713.2M 64.61M 2026-03
Myriad Genetics USD 212.8M 16.2M 2025-12
OraSure Technologies USD 40.35M 2.45M 2025-12
Pacific Biosciences Of California USD 97.83M 41.29M 2025-12
Quest Diagnostics USD 2.5B 76M 2026-03
Quidel USD 1.85B 1.09B 2026-03
Repligen USD 174.27M 3.67M 2026-03
Revvity USD 628.34M 2.12M 2026-03
Standard Biotools USD 45.72M 2.7M 2025-12
Thermo Fisher Scientific USD 9.09B 821M 2026-03
Veracyte USD 119.99M 3.99M 2026-03
Waters USD 1.12B 457.15M 2026-03